Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma

Urology

Volumn 50, Issue 3, 1997, Pages 446-448

  Loggie, B W ^a   Fleming, R A ^b   Hosseinian, A A ^b  

^a Section on Hematology and Oncology   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CARCINOMATOUS PERITONITIS; CASE REPORT; CHOLECYSTECTOMY; CLINICAL FEATURE; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; CYSTECTOMY; HEMATURIA; HUMAN; MALE; PELVIS EXENTERATION; PRIORITY JOURNAL; SIGMOIDECTOMY; SIGNET RING CARCINOMA; URACHUS;

ADULT; CARCINOMA, SIGNET RING CELL; COMBINED MODALITY THERAPY; HUMANS; MALE; PERITONEAL NEOPLASMS; URACHUS;

EID: 0030858169     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00247-1     Document Type: Article

References (14)

1. Loggie BW, Geisinger KR, and Fleming RA: Peritoneal carcinomatosis: survival after cytoreductive surgery with intraperitoneal heated chemotherapy (abstract). Proc Annu Meet Am Soc Clin Oncol 15: A1795, 1996.
2. Sheldon CA, Clayman RV, Gonzalez R, Williams RD, and Fraley EE: Malignant urachal lesions. J Urol 131: 1-8, 1984.
3. Ravi R, Shrivastava BR, Chandrasekhar GM, Prahlad S, Balasubramanian KV, and Mallikarjuna VS: Adenocarcinoma of the urachus. J Surg Oncol 50: 201-203, 1992.
4. Fiter L, Gimeno F, Martin L, and Gomez Tejeda L: Signet-ring cell adenocarcinoma of bladder. Urology 41: 30-33, 1993.
5. Weiss AM, Jeandal R, Lugagne-Delpon PM, Kamalodine T, and Barbanel C: Primary signet ring adenocarcinoma of a diverted neurogenic bladder. Ann Pathol 15: 131-133, 1995.
6. Vergos M, Messina MH, Lhomme Desages B, and Chapuis O: Cancer of the urachus. A rare form of tumors in the bladder. J Urol (Paris) 98: 56-59, 1992.
7. Chen KT, Workman RD, and Rainwater G: Urachal signet-ring cell carcinoma. Urology 36: 339-340, 1990.
8. Herr HW: Urachal carcinoma: the case for extended partial cystectomy. J Urol 151: 365-366, 1994.
9. Kakizoe T, Matsumoto K, Andoh M, Nishio Y, and Kishi K: Adenocarcinoma of the urachus. Report of 7 cases and review of literature. Urology 21: 360-366, 1983.
10. Baker AR, and Weber JS: Treatment of malignant ascites, in DeVita VTJ, Hellman S, and Rosenburg SA (Eds): Cancer: Principles and Practice of Oncology. Philadelphia, JB Lippincott, 1993, pp 2255-2261.
11. Chu DZ, Lang NP, Thompson C, Osteen PK, and Westbrook KC: Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 63: 364-367, 1989.
12. Gilly FN, Carry PY, Brachet A, Sayag AC, Panteix G, Salle B, Bienvenu J, Banssillon V, Burgard G, Manchon M, et al: Treatment of malignant peritoneal effusion in digestive and ovarian cancer. Med Oncol Tumor Pharmacother 9: 177-181, 1992.
13. Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K, Kiuchi S, Okui K, Miyoshi T, Arimizu N, et al: Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 208: 36-41, 1988.
14. Loggie BW, Perini M, Fleming RA, Russell GB, and Geisinger K: Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy. Am Surg 63: 137-143, 1997.